Rhynchophylline

Rhynchophylline at a Glance

Rhynchophylline is the marker tetracyclic oxindole alkaloid of the Chinese Uncaria — chiefly U. rhynchophylla, the hooked vine known in Chinese medicine as gou teng — and is also present in Amazonian cat’s claw (U. tomentosa). It is the molecule most often invoked to explain gou teng’s traditional use for hypertension, dizziness, convulsions and “wind” disorders.

Its two best-characterized activities are cardiovascular — an endothelium-independent vasodilator that blocks L-type calcium channels, demonstrated even in isolated human artery — and neurological, where it behaves as a non-competitive NMDA-receptor antagonist ^{4,5Reference 4Kang TH et al. · 2002Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytesView study →Reference 5Xu DD et al. · 2012AnimalRhynchophylline protects cultured rat neurons against methamphetamine cytotoxicityView study →}. That NMDA action is the mechanistic thread under a genuine set of preclinical neuroprotective and anti-addiction findings.

Two honest caveats frame everything below. First, all of this is preclinical — isolated tissue, cell culture and rodents; there is no human trial of the isolate. Second, although rhynchophylline is a shared Uncaria/Mitragyna oxindole alkaloid, it is only a minor and highly variable alkaloid of kratom — the pharmacology was worked out in Uncaria, and reading it onto a cup of kratom is not supported. A marker alkaloid is not the whole plant.

Rhynchophylline vs. the Uncaria Alkaloids

Uncaria carries two chemically distinct alkaloid families, and keeping them straight is the point.

• Oxindole alkaloids — a spiro-oxindole core, split into tetracyclic and pentacyclic ring systems. Rhynchophylline is the marquee tetracyclic oxindole; its co-alkaloid mitraphylline is the marquee pentacyclic oxindole (an anti-inflammatory signal). Rhynchophylline’s own stereoisomer, isorhynchophylline, differs only in configuration at the spiro-centre yet is routinely studied alongside it — the two share NMDA antagonism and vasodilation, and interconvert on heating ^{4,5Reference 4Kang TH et al. · 2002Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytesView study →Reference 5Xu DD et al. · 2012AnimalRhynchophylline protects cultured rat neurons against methamphetamine cytotoxicityView study →}.
• Indole alkaloids — the non-oxindole scaffold, represented by hirsutine (the calcium-channel-blocking, antiviral corynanthe-indole).

So gou teng’s cardiovascular story is really two molecules from two families pointing the same way: the tetracyclic oxindole rhynchophylline and the corynanthe-indole hirsutine both block calcium channels and relax vessels ^{1,2Reference 1Endo K et al. · 1983Hypotensive principles of Uncaria hooksView study →Reference 2Zhang WB et al. · 2004In vitroIn vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel)View study →}.

Do not confuse rhynchophylline with kratom’s mitragynine. Mitragynine is a corynanthe indole alkaloid and a µ-opioid partial agonist — a different scaffold with a different receptor. Rhynchophylline is an oxindole with no opioid activity; the molecules co-occur in the Rubiaceae but are not pharmacological substitutes.

Not a Kratom Effect

Rhynchophylline appears on kratom pages because Mitragyna speciosa and Uncaria both sit in the Rubiaceae and share several oxindole alkaloids. But in kratom it is a minor, strain- and season-variable component, dwarfed by mitragynine — itself the dominant alkaloid (up to ~5% of dry leaf and highly season/provenance-dependent) — and its potent metabolite 7-hydroxymitragynine, the alkaloids that actually drive kratom’s opioid, stimulant and sedative profile ^{15Reference 15Sengnon N et al. · 2023Seasonal and geographic variation in alkaloid content of kratom (Mitragyna speciosa (Korth.) Havil.) from ThailandView study →}.

Every cardiovascular, NMDA and neuroprotective finding below was generated in Uncaria material — isolated alkaloid, gou teng extract, or the pure compound in cell/animal models — not from kratom ingestion. The honest reading: rhynchophylline is a real, interesting molecule, but its documented pharmacology belongs to Uncaria, and it should not be used to infer what kratom does.

What It's Used For

Rhynchophylline’s literature is coherent and mechanistically specific — an L-type calcium-channel blocker with NMDA-antagonist neuroactivity — but entirely preclinical.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. No human isolate data, so scores stay low by design; the cardiovascular row edges up only because some work used human vascular tissue.

01CardiovascularShaky38%Concordant L-type Ca²⁺-block vasodilation incl. human artery + animal hypotension ^{1,2,3Reference 1Endo K et al. · 1983Hypotensive principles of Uncaria hooksView study →Reference 2Zhang WB et al. · 2004In vitroIn vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel)View study →Reference 3Li PY et al. · 2013Rhynchophylline-induced vasodilation in human mesenteric artery is mainly due to blockage of L-type calcium channels in vascular smooth muscle cellsView study →}

02NeuroprotectiveShaky32%NMDA antagonism + MPP⁺/methamphetamine/ischemia models ^{4,5,6,8Reference 4Kang TH et al. · 2002Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytesView study →Reference 5Xu DD et al. · 2012AnimalRhynchophylline protects cultured rat neurons against methamphetamine cytotoxicityView study →Reference 6Hu S et al. · 2018Neuroprotection against MPP⁺-induced cytotoxicity through the activation of PI3-K/Akt/GSK3β/MEF2D signaling pathway by rhynchophylline, the major tetracyclic oxindole alkaloid isolated from Uncaria rhynchophyllaView study →Reference 8Zhou J · 2010Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activityView study →}

03Anti-inflammatoryShaky22%LPS-microglia cytokine/MAPK-NF-κB suppression ^{9,10,11Reference 9Yuan D et al. · 2009AnimalAnti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanismView study →Reference 10Song Y et al. · 2012Rhynchophylline attenuates LPS-induced pro-inflammatory responses through down-regulation of MAPK/NF-κB signaling pathways in primary microgliaView study →Reference 11Geetha RG · 2021Recent advances in the anti-inflammatory activity of plant-derived alkaloid rhynchophylline in neurological and cardiovascular diseasesView study →}

04Anti-addictionShaky18%NR2B down-regulation in amphetamine place-preference rats ^{7Reference 7Zhou JY et al. · 2010AnimalRhynchophylline down-regulates NR2B expression in cortex and hippocampal CA1 area of amphetamine-induced conditioned place preference ratView study →}

Mechanisms

The load-bearing point is that one molecule reaches two systems through calcium: it blocks L-type Ca²⁺ channels in blood vessels (vasodilation) and, separately, antagonizes the Ca²⁺-permeable NMDA receptor in neurons (neuroprotection). Different channels, same theme.

Pharmacokinetics

Rhynchophylline’s pharmacokinetics are characterized only in rodents. After oral dosing in mice its oral bioavailability was ~49% with a rapid clearance (terminal half-life within a 0.6–4.4 h range across the six co-measured Uncaria alkaloids) ^{13Reference 13Chen L et al. · 2020AnimalSimultaneous determination of six Uncaria alkaloids in mouse blood by UPLC-MS/MS and its application in pharmacokinetics and bioavailabilityView study →}; in rats it and its isomer isorhynchophylline undergo extensive phase-I biotransformation (oxidation/hydroxylation and related metabolites) ^{14Reference 14Jiang S et al. · 2022AnimalBiotransformation and pharmacokinetic studies of four alkaloids from Uncaria rhynchophylla in rat plasma by ultra-performance liquid chromatography with tandem mass spectrometryView study →}, and a Uncaria-hook review notes CYP-mediated metabolism, measurable brain distribution consistent with its central actions, and generally modest, variable oral exposure typical of the alkaloid class ^{12Reference 12Kushida H et al. · 2021Properties, pharmacology and pharmacokinetics of active indole and oxindole alkaloids in Uncaria hookView study →}. There is no validated human pharmacokinetic data.

Clinical Trials

There are no human trials of isolated rhynchophylline. All cardiovascular, NMDA/neuroprotective, anti-inflammatory and anti-addiction data are in-vitro (including human vascular tissue) or animal; human Uncaria/gou teng use is traditional and extract-based, not attributable to this single molecule.

Last checked: July 2026.

Isolate vs. Plant Studies

The evidence is unusually isolate-forward for a botanical alkaloid: rhynchophylline (and its isomer isorhynchophylline) have been purified and tested directly in vessels, oocytes, neurons and microglia ^{2,4,9Reference 2Zhang WB et al. · 2004In vitroIn vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel)View study →Reference 4Kang TH et al. · 2002Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytesView study →Reference 9Yuan D et al. · 2009AnimalAnti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanismView study →}, and the standout cardiovascular experiment used isolated human artery smooth muscle rather than a rodent surrogate ^{3Reference 3Li PY et al. · 2013Rhynchophylline-induced vasodilation in human mesenteric artery is mainly due to blockage of L-type calcium channels in vascular smooth muscle cellsView study →}. That is a genuine mechanistic strength. What is missing is the other end: there is no human dosed study of the isolate, and gou teng’s actual human use is as a whole hook/extract where rhynchophylline co-acts with isorhynchophylline, corynoxeine, hirsutine and geissoschizine methyl ether ^{12Reference 12Kushida H et al. · 2021Properties, pharmacology and pharmacokinetics of active indole and oxindole alkaloids in Uncaria hookView study →} — and indeed the whole ethanolic gou teng extract is itself a documented vasodilator through overlapping calcium-channel and endothelial pathways ^{16Reference 16Loh YC et al. · 2017Mechanisms of action of Uncaria rhynchophylla ethanolic extract for its vasodilatory effectsView study →}. So the mechanism is well-isolated but the clinical benefit is not — do not read gou teng’s traditional record as rhynchophylline’s alone.

Prevalence in Nature

Rhynchophylline is a hook/stem alkaloid of the genus Uncaria (Rubiaceae). Its richest and best-studied source is the Chinese gou teng, Uncaria rhynchophylla — the hooked branchlets used in Chinese medicine — where it and isorhynchophylline are the marker tetracyclic oxindoles; it also occurs in U. sinensis, U. macrophylla and Amazonian cat’s claw (U. tomentosa) ^{17Reference 17Heitzman ME et al. · 2005Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae)View study →}. Total oxindole-alkaloid content in Uncaria is low — on the order of tenths of a percent of dry material — and varies widely with species, plant part, chemotype and season ^{17Reference 17Heitzman ME et al. · 2005Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae)View study →}.

Beyond Uncaria, rhynchophylline is one of several oxindole alkaloids shared with kratom (Mitragyna speciosa), but there it is a minor and highly variable constituent, not a defining one ^{15Reference 15Sengnon N et al. · 2023Seasonal and geographic variation in alkaloid content of kratom (Mitragyna speciosa (Korth.) Havil.) from ThailandView study →}. Quantitative per-source figures for the free alkaloid are sparse in the accessible literature; the specific ranges are logged as a gap to chase rather than guessed at here.

Discovery & Synthesis

Rhynchophylline was isolated from Uncaria rhynchophylla by mid-20th-century natural-product chemists working on the traditional Chinese “gou teng” hook; the exact first-isolation date and worker are not cleanly documented in the accessible literature, and the compound is named directly for its source species (rhynchophylla). Its structure is a spiro-oxindole with a tetracyclic ring system, and it exists in equilibrium with its C-7 epimer isorhynchophylline, the two interconverting under heat — a fact that complicates both isolation and any “single-alkaloid” quantitation ^{4,17Reference 4Kang TH et al. · 2002Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytesView study →Reference 17Heitzman ME et al. · 2005Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae)View study →}.

Because Uncaria alkaloids are structurally intricate spiro-oxindoles and are present at low natural abundance, practical supply is still overwhelmingly by extraction from gou teng, and rhynchophylline functions in practice as a standardization/quality marker for the herb rather than a manufactured drug substance. A first total synthesis and a modern preparative route are not well documented here.

Patents: not yet researched.

Toxicity & Safety

Rhynchophylline carries a low flag on the available preclinical data — no LD50 or dedicated toxicology package for the isolate was located, and its active concentrations sit in the µM range. As with its sibling hirsutine, the honest qualifier is pharmacology, not documented harm: rhynchophylline is genuinely cardioactive (an L-type calcium-channel blocker with review-level antiarrhythmic activity) and centrally active (NMDA antagonism, sedative effects in the traditional literature), so its plausible risks follow from those mechanisms.

Safety at a Glance

✅ Low / no toxicityCardiac cautionDrug interactions

• Not mitragynine, not an opioid. A distinct oxindole scaffold; kratom’s opioid and dependence pharmacology does not apply.
• Cardioactive at pharmacological exposures. As an L-type Ca²⁺-channel blocker it is plausibly hypotensive/bradycardic and antiarrhythmic — the same properties that make it interesting make it something to respect.
• Additive with cardiovascular drugs. Plausibly additive with calcium-channel blockers, antihypertensives and antiarrhythmics.
• Central activity. NMDA antagonism and sedative/anticonvulsant signals mean additive CNS effects are conceivable with sedatives.
• No human safety data or LD50. No genotoxicity or repeat-dose toxicology for the isolate was located; cardioactivity is inferred pharmacology, not a measured harm.

Full Safety & Interactions Detail

Rhynchophylline has a low verdict on the available preclinical data — no LD50, genotoxicity or repeat-dose study for the isolate was located, and its documented activity (vasodilation, NMDA antagonism, microglial anti-inflammation) sits at µM concentrations ^{2,4,9Reference 2Zhang WB et al. · 2004In vitroIn vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel)View study →Reference 4Kang TH et al. · 2002Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytesView study →Reference 9Yuan D et al. · 2009AnimalAnti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanismView study →}.

The load-bearing caution is pharmacology, not toxicity signal: it is a genuine L-type calcium-channel blocker and is described with antiarrhythmic and central (NMDA-antagonist, sedative/anticonvulsant) activity in the review literature ^{11,12Reference 11Geetha RG · 2021Recent advances in the anti-inflammatory activity of plant-derived alkaloid rhynchophylline in neurological and cardiovascular diseasesView study →Reference 12Kushida H et al. · 2021Properties, pharmacology and pharmacokinetics of active indole and oxindole alkaloids in Uncaria hookView study →}, so at pharmacological exposures the plausible risks are hypotension, bradycardia and conduction effects, with additive interaction with calcium-channel blockers, antihypertensives and antiarrhythmics, and additive CNS effects with sedatives. It is chemically and pharmacologically distinct from kratom’s mitragynine: it has no opioid activity, and kratom’s dependence/respiratory profile must not be attributed to it.

Reproductive note (prose only). No dedicated reproductive-toxicity dataset exists for isolated rhynchophylline, and Uncaria species are traditionally cautioned in pregnancy; pregnancy/lactation decisions belong on the herb or product page where intake is decided, not on this molecule page.

Dosage

There is no established human dose for isolated rhynchophylline, and it is not a standalone supplement — it functions as a standardization marker for gou teng (Uncaria rhynchophylla) extracts, not a dosed ingredient. The evidence exists only as in-vitro concentrations (µM-range vasodilation and NMDA antagonism; ~43 µM NMDA IC50) ^{4Reference 4Kang TH et al. · 2002Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytesView study →} and animal doses (oral rodent pharmacokinetic and behavioural studies) ^{7,13Reference 7Zhou JY et al. · 2010AnimalRhynchophylline down-regulates NR2B expression in cortex and hippocampal CA1 area of amphetamine-induced conditioned place preference ratView study →Reference 13Chen L et al. · 2020AnimalSimultaneous determination of six Uncaria alkaloids in mouse blood by UPLC-MS/MS and its application in pharmacokinetics and bioavailabilityView study →} — none of which is an oral human recommendation. These are concentrations and doses studied in research and are not a personal recommendation.

References

1. Endo K, Oshima Y, Kikuchi H, Koshihara Y, Hikino H (1983). Hypotensive principles of Uncaria hooks. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/6657789/
2. Zhang WB, Chen CX, Sim SM, Kwan CY (2004). In vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel). Naunyn-Schmiedeberg’s Archives of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/14668978/
3. Li PY, Zeng XR, Cheng J, Wen J, Inoue I, Yang Y (2013). Rhynchophylline-induced vasodilation in human mesenteric artery is mainly due to blockage of L-type calcium channels in vascular smooth muscle cells. Naunyn-Schmiedeberg’s Archives of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/23812676/
4. Kang TH, Murakami Y, Matsumoto K, Takayama H, Kitajima M, Aimi N, Watanabe H (2002). Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytes. European Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/12433591/
5. Xu DD, Hoeven R, Rong R, Cho WC (2012). Rhynchophylline protects cultured rat neurons against methamphetamine cytotoxicity. Evidence-Based Complementary and Alternative Medicine. https://pubmed.ncbi.nlm.nih.gov/22619690/
6. Hu S, Mak S, Zuo X, Li H, Wang Y, Han Y (2018). Neuroprotection against MPP⁺-induced cytotoxicity through the activation of PI3-K/Akt/GSK3β/MEF2D signaling pathway by rhynchophylline, the major tetracyclic oxindole alkaloid isolated from Uncaria rhynchophylla. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/30072894/
7. Zhou JY, Mo ZX, Zhou SW (2010). Rhynchophylline down-regulates NR2B expression in cortex and hippocampal CA1 area of amphetamine-induced conditioned place preference rat. Archives of Pharmacal Research. https://pubmed.ncbi.nlm.nih.gov/20422365/
8. Zhou J, Zhou S (2010). Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/20736055/
9. Yuan D, Ma B, Yang JY, Xie YY, Wang L, Zhang LJ, Kano Y, Wu CF (2009). Anti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanism. International Immunopharmacology. https://pubmed.ncbi.nlm.nih.gov/19781666/
10. Song Y, Qu R, Zhu S, Zhang R, Ma S (2012). Rhynchophylline attenuates LPS-induced pro-inflammatory responses through down-regulation of MAPK/NF-κB signaling pathways in primary microglia. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/22322985/
11. Geetha RG, Ramachandran S (2021). Recent advances in the anti-inflammatory activity of plant-derived alkaloid rhynchophylline in neurological and cardiovascular diseases. Pharmaceutics. https://pubmed.ncbi.nlm.nih.gov/34452133/
12. Kushida H, Matsumoto T, Ikarashi Y (2021). Properties, pharmacology and pharmacokinetics of active indole and oxindole alkaloids in Uncaria hook. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/34335255/
13. Chen L, Ma J, Wang X, Zhang M (2020). Simultaneous determination of six Uncaria alkaloids in mouse blood by UPLC-MS/MS and its application in pharmacokinetics and bioavailability. BioMed Research International. https://pubmed.ncbi.nlm.nih.gov/32879877/
14. Jiang S, Yang X, Wang Z, Gan C, Huang J, Sun J, Peng H, Wei F, Wang Z, Yang C (2022). Biotransformation and pharmacokinetic studies of four alkaloids from Uncaria rhynchophylla in rat plasma by ultra-performance liquid chromatography with tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. https://pubmed.ncbi.nlm.nih.gov/35691093/
15. Sengnon N, Vonghirundecha P, Chaichan W, Juengwatanatrakul T, Onthong J, Kitprasong P, Sriwiriyajan S, Chittrakarn S, Limsuwanchote S, Wungsintaweekul J (2023). Seasonal and geographic variation in alkaloid content of kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand. Plants (Basel). https://pubmed.ncbi.nlm.nih.gov/36840297/
16. Loh YC, Ch’ng YS, Tan CS, Ahmad M, Asmawi MZ, Yam MF (2017). Mechanisms of action of Uncaria rhynchophylla ethanolic extract for its vasodilatory effects. Journal of Medical Food. https://pubmed.ncbi.nlm.nih.gov/28771084/
17. Heitzman ME, Neto CC, Winiarz E, Vaisberg AJ, Hammond GB (2005). Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae). Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/15649507/

View all 17 references▾